Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1251681

Chemobrachyradiotherapy and consolidation chemotherapy in treatment of locally advanced cervical cancer


Tomić, Krešimir; Berić Jozić, Gordana; Parić, Ana; Marijanović, Inga; Lasić, Ivan; Soldo, Dragan; Vrdoljak, Eduard
Chemobrachyradiotherapy and consolidation chemotherapy in treatment of locally advanced cervical cancer // Wiener klinische Wochenschrift, 133 (2021), 21-22; 1155-1161 doi:10.1007/s00508-021-01958-0 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1251681 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Chemobrachyradiotherapy and consolidation chemotherapy in treatment of locally advanced cervical cancer

Autori
Tomić, Krešimir ; Berić Jozić, Gordana ; Parić, Ana ; Marijanović, Inga ; Lasić, Ivan ; Soldo, Dragan ; Vrdoljak, Eduard

Izvornik
Wiener klinische Wochenschrift (0043-5325) 133 (2021), 21-22; 1155-1161

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Squamous cell carcinoma ; Chemoradiotherapy ; Radiotherapy ; Brachytherapy ; Adjuvant chemotherapy

Sažetak
Background: Given the lack of primary and secondary prevention programs and cancer awareness in general, cervical cancer remains one of the main causes of cancer-related death in developing countries, such as Bosnia and Herzegovina. Optimization of combinations of external radiation therapy (ERT), brachytherapy and chemotherapy is still needed to improve outcomes in the treatment of advanced cervical cancer. Patients and methods: We retrospectively analyzed 48 consecutive patients with Federation Internationale de Gynecologie et d'Obstetrique (FIGO) 2009 stage IB2-IVA, who were treated with primary concomitant chemobrachyradiotherapy (CCBRT) and consolidation chemotherapy at the Department of Oncology, University Hospital Mostar, Bosnia and Herzegovina between December 2012 and June 2020. Patients were treated with ERT plus two cycles of concomitant chemobrachytherapy with ifosfamide and cisplatin and low-dose rate (LDR) brachytherapy followed by four cycles of consolidation chemotherapy at 3- week intervals. We evaluated local control rate (LCR), disease-free survival (DFS), overall survival (OS), disease-specific survival (DSS) and toxicity. Results: After 45.5 months (interquartile range, IQR = 47 months) of median follow-up, 5-year DFS was 72.8% (95% confidence interval. CI 59-78%), OS was 76.6% (95% CI 60- 79%), and DSS was 88% (95% CI 71-86%) with acceptable toxicity. LCR was 94%. Conclusion: Primary CCBRT and consolidation chemotherapy applied in standard clinical practice in the treatment of locally advanced cervical cancer (LACC) produce respectable outcomes.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
KBC Split,
Medicinski fakultet, Split

Profili:

Avatar Url Dragan Soldo (autor)

Avatar Url Eduard Vrdoljak (autor)

Poveznice na cjeloviti tekst rada:

doi link.springer.com

Citiraj ovu publikaciju:

Tomić, Krešimir; Berić Jozić, Gordana; Parić, Ana; Marijanović, Inga; Lasić, Ivan; Soldo, Dragan; Vrdoljak, Eduard
Chemobrachyradiotherapy and consolidation chemotherapy in treatment of locally advanced cervical cancer // Wiener klinische Wochenschrift, 133 (2021), 21-22; 1155-1161 doi:10.1007/s00508-021-01958-0 (međunarodna recenzija, članak, znanstveni)
Tomić, K., Berić Jozić, G., Parić, A., Marijanović, I., Lasić, I., Soldo, D. & Vrdoljak, E. (2021) Chemobrachyradiotherapy and consolidation chemotherapy in treatment of locally advanced cervical cancer. Wiener klinische Wochenschrift, 133 (21-22), 1155-1161 doi:10.1007/s00508-021-01958-0.
@article{article, author = {Tomi\'{c}, Kre\v{s}imir and Beri\'{c} Jozi\'{c}, Gordana and Pari\'{c}, Ana and Marijanovi\'{c}, Inga and Lasi\'{c}, Ivan and Soldo, Dragan and Vrdoljak, Eduard}, year = {2021}, pages = {1155-1161}, DOI = {10.1007/s00508-021-01958-0}, keywords = {Squamous cell carcinoma, Chemoradiotherapy, Radiotherapy, Brachytherapy, Adjuvant chemotherapy}, journal = {Wiener klinische Wochenschrift}, doi = {10.1007/s00508-021-01958-0}, volume = {133}, number = {21-22}, issn = {0043-5325}, title = {Chemobrachyradiotherapy and consolidation chemotherapy in treatment of locally advanced cervical cancer}, keyword = {Squamous cell carcinoma, Chemoradiotherapy, Radiotherapy, Brachytherapy, Adjuvant chemotherapy} }
@article{article, author = {Tomi\'{c}, Kre\v{s}imir and Beri\'{c} Jozi\'{c}, Gordana and Pari\'{c}, Ana and Marijanovi\'{c}, Inga and Lasi\'{c}, Ivan and Soldo, Dragan and Vrdoljak, Eduard}, year = {2021}, pages = {1155-1161}, DOI = {10.1007/s00508-021-01958-0}, keywords = {Squamous cell carcinoma, Chemoradiotherapy, Radiotherapy, Brachytherapy, Adjuvant chemotherapy}, journal = {Wiener klinische Wochenschrift}, doi = {10.1007/s00508-021-01958-0}, volume = {133}, number = {21-22}, issn = {0043-5325}, title = {Chemobrachyradiotherapy and consolidation chemotherapy in treatment of locally advanced cervical cancer}, keyword = {Squamous cell carcinoma, Chemoradiotherapy, Radiotherapy, Brachytherapy, Adjuvant chemotherapy} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font